THE RELATION OF CENTRAL 5-HT1A AND 5-HT2 RECEPTORS - LOW-DOSE AGONIST-INDUCED SELECTIVE TOLERANCE IN THE RAT

被引:34
作者
PRANZATELLI, MR
PLUCHINO, RS
机构
[1] GEORGE WASHINGTON UNIV,DEPT NEUROL,WASHINGTON,DC 20010
[2] GEORGE WASHINGTON UNIV,DEPT PEDIAT,WASHINGTON,DC 20010
[3] GEORGE WASHINGTON UNIV,DEPT PHARMACOL,WASHINGTON,DC 20010
关键词
5-HT1A RECEPTORS; 5-HT2; RECEPTORS; TOLERANCE; SEROTONIN SYNDROME; SKIN JERKS; SHAKING BEHAVIOR;
D O I
10.1016/0091-3057(91)90199-C
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
To study the purported relation of 5-HT1A and 5-HT2 receptors, we chronically injected rats with a low dose of selective 5-HT agonists to induce behavioral tolerance and then tested for cross-tolerance. Acutely, in naive rats, both the putative 5-HT2 agonist DOI and the 5-HT1A agonist 8-OH-DPAT induced some behaviors of the "serotonin syndrome" but the two drugs could be differentiated. Only DOI evoked shaking behavior, "skin jerks" (spinal myoclonus), and hyperthermia. Only 8-OH-DPAT induced flat body posture, head weaving, hypothermia, and occasional hindlimb hyperextension (dystonic posture). Both drugs, especially 8-OH-DPAT, evoked forepaw tapping. Chronic (21 day) treatment with DOI prevented DOI-evoked behaviors but not behaviors evoked by 8-OH-DPAT. Behaviors evoked by 8-OH-DPAT and not DOI decreased significantly after chronic 8-OH-DPAT treatment. Development of selective tolerance suggests that putative selective 5-HT2 and 5-HT1A agonists exert both shared and distinctive behavioral effects through separate sites whose relation is behavior-specific. For some behaviors (forepaw myoclonus, shaking behavior, thermoregulation), there is a functional interaction between 5-HT1A and 5-HT2 sites, while for other behaviors (skin jerks, flat body posture, head weaving), there is no interaction.
引用
收藏
页码:407 / 413
页数:7
相关论文
共 47 条
[1]  
ARANEDA R C, 1988, Society for Neuroscience Abstracts, V14, P846
[2]   FACILITATION OF 8-OHDPAT-INDUCED FOREPAW TREADING OF RATS BY THE 5-HT2 AGONIST DOI [J].
ARNT, J ;
HYTTEL, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 161 (01) :45-51
[3]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[4]   ANOREXIA AND BRAIN-SEROTONIN - DEVELOPMENT OF TOLERANCE TO THE EFFECTS OF FENFLURAMINE AND QUIPAZINE IN RATS WITH SEROTONIN-DEPLETING LESIONS [J].
CARLTON, J ;
ROWLAND, N .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 20 (05) :739-745
[5]   THE HEAD-TWITCH RESPONSE TO INTRAPERITONEAL INJECTION OF 5-HYDROXYTRYPTOPHAN IN THE RAT - ANTAGONIST EFFECTS OF PURPORTED 5-HYDROXYTRYPTAMINE ANTAGONISTS AND OF PIRENPERONE, AN LSD ANTAGONIST [J].
COLPAERT, FC ;
JANSSEN, PAJ .
NEUROPHARMACOLOGY, 1983, 22 (08) :993-1000
[6]   EVIDENCE FOR EXCITATORY 5-HT2-RECEPTORS ON RAT BRAIN-STEM NEURONS [J].
DAVIES, M ;
WILKINSON, LS ;
ROBERTS, MHT .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :483-491
[7]  
DESOUZA RJ, 1986, BRIT J PHARMACOL, V89, P373
[8]   THE EFFECTS OF LESIONS PRODUCED BY 5,7-DIHYDROXYTRYPTAMINE ON 5-HYDROXYTRYPTAMINE-MEDIATED BEHAVIOR INDUCED BY AMPHETAMINE IN LARGE DOSES IN THE RAT [J].
DICKINSON, SL ;
ANDREWS, CD ;
CURZON, G .
NEUROPHARMACOLOGY, 1984, 23 (04) :423-429
[9]   REDUCTION IN CORTICAL 5HT2 RECEPTOR SENSITIVITY AFTER CONTINUOUS GEPIRONE TREATMENT [J].
EISON, AS ;
YOCCA, FD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 111 (03) :389-392
[10]  
FRIEDMAN RL, 1984, J PHARMACOL EXP THER, V228, P628